Review
Open access
Sep 2026
siRNA therapeutics for metabolic dysfunction-associated Steatohepatitis: Targets, delivery, clinical evidence, and translational challenges
This review critically evaluates target selection, delivery, clinical and preclinical evidence, unsuccessful programs, competing nucleic acid modalities, and combination strategies in metabolic dysfunction-associated steatotic liver disease.
Ya-Nan Guo, Qun-Yan Yao
· Biochemistry and Biophysics... · 0 citations